Ronald L. Dubowy
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Melanoma and MAPK Pathways
Most-Cited Works
- → SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis(2017)350 cited
- → Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498 [see comments](1992)257 cited
- → A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia(2015)239 cited
- → Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study(2022)223 cited
- → Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial(2017)198 cited
- → Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): Report of the Head Start I and II experience(2007)139 cited
- → Intensive Therapy With Growth Factor Support for Patients With Ewing Tumor Metastatic at Diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457—A Report From the Children's Oncology Group(2005)137 cited
- → A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.(1998)129 cited
- → A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation(1998)115 cited
- → Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue(2006)113 cited